Regulations.gov document
Background Material re Pfizer Inc - Tab A - Letter from Pfizer dated March 21, 2007, in…
Supporting & Related Material · FDA-2007-P-0350 · posted Jun 10, 2008
Key facts
| Document ID | FDA-2007-P-0350-0005 |
|---|---|
| Title | Background Material re Pfizer Inc - Tab A - Letter from Pfizer dated March 21, 2007, in response to Novartis's repudiation of the License Agreement, notifying FDA that Pfizer is revoking Novartis's right of reference to Pfizer's amlodipine IND and NDA, effective midnight, March 25, 2007 |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2007-P-0350 |
| Posted | Jun 10, 2008 |
| Effective date | Mar 21, 2007 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: